GURUFOCUS.COM » STOCK LIST » Technology » Software » Nuance Communications Inc (NAS:NUAN) » Definitions » Valuation Rank

Nuance Communications (Nuance Communications) Valuation Rank


View and export this data going back to 1995. Start your Free Trial

What is Nuance Communications Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Nuance Communications Valuation Rank Related Terms

Thank you for viewing the detailed overview of Nuance Communications's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuance Communications (Nuance Communications) Business Description

Traded in Other Exchanges
N/A
Address
1 Wayside Road, Burlington, MA, USA, 01803
Nuance Communications Inc is the pioneer in conversational AI innovations that bring intelligence to everyday work and life. The company delivers solutions that understand, analyze, and respond to people amplifying human intelligence to increase productivity and security. Its operating segment includes Healthcare; Enterprise; and Other. The company generates maximum revenue from the Healthcare segment. Its Healthcare segment is primarily engaged in providing clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement. Geographically, it derives a majority of revenue from the United States.
Executives
Lloyd Carney director C/O MICROMUSE INC, 139 TOWNSEND ST, SAN FRANCISCO CA 94107
Robert Dahdah officer: Executive Vice President and C C/O NUANCE COMMUNICATIONS, INC. ONE WAYSIDE ROAD BURLINGTON MA 01803
Mark D Benjamin director, officer: Chief Executive Officer NUANCE COMMUNICATIONS, INC., 1 WAYSIDE ROAD, BURLINGTON MA 01803
Robert Weideman officer: EVP & GM, Enterprise Division C/O SCANSOFT INC 9 CENTENNIAL DR PEABODY MA 01960
Daniel David Tempesta officer: EVP & Chief Financial Officer ONE WAYSIDE ROAD, BURLINGTON MA 01803
Sanjay Vaswani director
Joseph Carl Petro officer: Executive Vice President & Chi THREE RAVINIA DRIVE ATLANTA 2Q 30346
Arthur G. Giterman officer: SVP & Chief Accounting Officer 26 ELDRED STREET LEXINGTON MA 02420
Wendy Cassity officer: EVP & Chief Legal Officer C/O XPO, INC., FIVE AMERICAN LANE, GREENWICH CT 06831
Thomas L Beaudoin officer: EVP, Business Transformation NUANCE COMMUNICATIONS, INC., 1 WAYSIDE ROAD, BURLINGTON MA 01803
Mark R Laret director VARIAN MEDICAL SYSTEMS INC 3100 HANSEN WAY MAIL STOP E327 PALO ALTO CA 94304
Daniel J. Brennan director BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Robert J Finocchio director C/O ALTERA CORP 101 INNOVATION DRIVE SAN JOSE CA 95134
Thomas D Ebling director C/O DEMANDWARE, INC. 5 WALL STREET BURLINGTON MA 01803
Laura S. Kaiser director 10101 WOODFIELD LANE, ST. LOUIS MO 63132